These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32759366)

  • 21. Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction.
    Umehara K; Cantrill C; Wittwer MB; Di Lenarda E; Klammers F; Ekiciler A; Parrott N; Fowler S; Ullah M
    Drug Metab Dispos; 2020 Oct; 48(10):849-860. PubMed ID: 32739889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance.
    De Bruyn T; Ufuk A; Cantrill C; Kosa RE; Bi YA; Niosi M; Modi S; Rodrigues AD; Tremaine LM; Varma MVS; Galetin A; Houston JB
    Drug Metab Dispos; 2018 Jul; 46(7):989-1000. PubMed ID: 29720472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Prediction of Positron Emission Tomography-Imaged Metformin Hepatic Uptake Clearance in Humans Using the Quantitative Proteomics-Informed Relative Expression Factor Approach.
    Sachar M; Kumar V; Gormsen LC; Munk OL; Unadkat JD
    Drug Metab Dispos; 2020 Nov; 48(11):1210-1216. PubMed ID: 32843330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics.
    Ishida K; Ullah M; Tóth B; Juhasz V; Unadkat JD
    Drug Metab Dispos; 2018 Jan; 46(1):66-74. PubMed ID: 29084782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consideration of albumin-mediated hepatic uptake for highly protein-bound anionic drugs: Bridging the gap of hepatic uptake clearance between in vitro and in vivo.
    Miyauchi S; Kim SJ; Lee W; Sugiyama Y
    Pharmacol Ther; 2022 Jan; 229():107938. PubMed ID: 34171335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current In Vitro Methods to Determine Hepatic Kp
    Riede J; Camenisch G; Huwyler J; Poller B
    J Pharm Sci; 2017 Sep; 106(9):2805-2814. PubMed ID: 28385545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism.
    Poulin P; Bteich M; Haddad S
    J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Guidance for the Prediction of Hepatic Clearance in the Early Drug Discovery and Development from the in Vitro-to-in Vivo Extrapolation Method and an Approach for Exploring Whether an Albumin-Mediated Hepatic Uptake Phenomenon Could be Present Under in Vivo Conditions.
    Poulin P; Haddad S
    J Pharm Sci; 2021 Jul; 110(7):2841-2858. PubMed ID: 33857483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Disconnect between Hepatocyte and Microsome Intrinsic Clearance and In Vitro In Vivo Extrapolation Performance.
    Williamson B; Harlfinger S; McGinnity DF
    Drug Metab Dispos; 2020 Nov; 48(11):1137-1146. PubMed ID: 32847864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Methods for Estimating Unbound Intracellular-to-Medium Concentration Ratios in Rat and Human Hepatocytes Using Statins.
    Yoshikado T; Toshimoto K; Nakada T; Ikejiri K; Kusuhara H; Maeda K; Sugiyama Y
    Drug Metab Dispos; 2017 Jul; 45(7):779-789. PubMed ID: 28468836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.
    Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P
    J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
    Manevski N; Umehara K; Parrott N
    Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters.
    Nozaki Y; Izumi S
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):56-70. PubMed ID: 31901416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.
    Ménochet K; Kenworthy KE; Houston JB; Galetin A
    Drug Metab Dispos; 2012 Sep; 40(9):1744-56. PubMed ID: 22665271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
    Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
    Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct Comparison of Total Clearance Prediction: Computational Machine Learning Model versus Bottom-Up Approach Using In Vitro Assay.
    Kosugi Y; Hosea N
    Mol Pharm; 2020 Jul; 17(7):2299-2309. PubMed ID: 32478525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the Dynamic Well-Stirred Model to Extrapolate Hepatic Clearance of Organic Anion-Transporting Polypeptide Transporter Substrates without Assuming Albumin-Mediated Hepatic Drug Uptake.
    Yan Z; Ma L; Hwang N; Huang J; Kenny JR; Hop CECA
    Drug Metab Dispos; 2024 May; 52(6):548-554. PubMed ID: 38604729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
    Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
    Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of uptake intrinsic clearance from attached rat hepatocytes to predict hepatic clearance for poorly permeable compounds.
    Huang L; Chen A; Roberts J; Janosky B; Be X; Berry L; Lin MH
    Xenobiotica; 2012 Sep; 42(9):830-40. PubMed ID: 22439758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.